Literature DB >> 1442389

The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients.

P L Choyke1, G M Glenn, M M Walther, B Zbar, G H Weiss, R B Alexander, W S Hayes, J P Long, K N Thakore, W M Linehan.   

Abstract

OBJECTIVE: Von Hippel-Lindau disease is a multisystem disorder predisposing to renal cysts and cancer. The growth and development of these renal lesions have not been documented previously. We reviewed serial CT scans to determine the rates and patterns of growth of renal lesions associated with von Hippel-Lindau disease. SUBJECTS AND METHODS: Twenty-eight patients with von Hippel-Lindau disease and renal involvement, including the spectrum from simple cysts to solid masses, had follow-up examinations for at least 1 year (mean, 2.4 years; range, 1-12 years) with serial contrast-enhanced abdominal CT. Renal lesions were measured and characterized. Surgical correlation was available in 12 patients.
RESULTS: Two hundred twenty-eight lesions (eight lesions per patient) were detected. On the basis of their CT appearance, 168 lesions (74%) were classified as cysts, 18 (8%) as cysts with solid components, and 42 (18%) as solid masses. Among 12 patients with pathologic confirmation, the solid components of cystic lesions and solid lesions almost always contained renal carcinoma. The majority of cysts remained the same size (71%) or enlarged (20%); 9% became smaller or entirely involuted during the follow-up period. Although it is generally presumed that renal cysts are precursors to cancers, the transformation of a simple cyst to a solid lesion was observed in only two patients. Among the 42 solid lesions, all but two enlarged with time, with a mean doubling time of 10 months.
CONCLUSION: The renal lesions associated with von Hippel-Lindau disease exhibited wide differences in growth. The majority of renal cysts grew slowly but some involuted. Transition to solid renal cancer was rare among cysts. Complex cystic and solid lesions contained neoplastic tissue that uniformly enlarged. These data may be used to help predict the progression of renal lesions in von Hippel-Lindau disease.

Entities:  

Mesh:

Year:  1992        PMID: 1442389     DOI: 10.2214/ajr.159.6.1442389

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Germline mutations in the VHL gene associated with 3 different renal lesions in a Chinese von Hippel-Lindau disease family.

Authors:  Ping Yuan; Qipeng Sun; Hao Liang; Wenjun Wang; Ling Li; Ye Wang; Huan Deng; Luhua Lai; Xiaoli Chen; Xiangfu Zhou
Journal:  Cancer Biol Ther       Date:  2016-04-08       Impact factor: 4.742

2.  Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.

Authors:  C A Jilg; Hartmut P H Neumann; S Gläsker; O Schäfer; C Leiber; P U Ardelt; M Schwardt; W Schultze-Seemann
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Authors:  Eric Jonasch; Ian E McCutcheon; Dan S Gombos; Kamran Ahrar; Nancy D Perrier; Diane Liu; Christine C Robichaux; Mercedes F Villarreal; Justin A Weldon; Ashley H Woodson; Patrick G Pilie; Gregory N Fuller; Steven G Waguespack; Surena F Matin
Journal:  Lancet Oncol       Date:  2018-09-17       Impact factor: 41.316

4.  Optimal follow-up intervals in active surveillance of renal masses in patients with von Hippel-Lindau disease.

Authors:  Fabio Pomerri; Giuseppe Opocher; Chiara Dal Bosco; Pier Carlo Muzzio; Gisella Gennaro
Journal:  Eur Radiol       Date:  2015-01-31       Impact factor: 5.315

Review 5.  Advances in the genetics of familial renal cancer.

Authors:  Patrick J Morrison; Deirdre E Donnelly; A Brew Atkinson; Alexander P Maxwell
Journal:  Oncologist       Date:  2010-05-19

6.  A Case of Von Hippel Lindau Disease.

Authors:  S Bhargava; A Rao; A Mishra
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 7.  Alterations in VHL as potential biomarkers in renal-cell carcinoma.

Authors:  Lucy Gossage; Tim Eisen
Journal:  Nat Rev Clin Oncol       Date:  2010-04-06       Impact factor: 66.675

8.  Active surveillance of renal masses in von Hippel-Lindau disease: growth rates and clinical outcome over a median follow-up period of 56 months.

Authors:  Jin Zhang; Jia-Hua Pan; Bai-Jun Dong; Wei Xue; Dong-Ming Liu; Yi-Ran Huang
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

9.  Percutaneous radio frequency ablation of small renal tumors: initial results.

Authors:  Christian P Pavlovich; McClellan M Walther; Peter L Choyke; Stephen E Pautler; Richard Chang; W Marston Linehan; Bradford J Wood
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

10.  Hereditary renal cell carcinoma associated with von Hippel-Lindau disease: a description of a Nova Scotia cohort.

Authors:  Shannon Bradley; Nadine Dumas; Mark Ludman; Lori Wood
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.